Desmoid Tumor: Clinical Trials

3 trials for Desmoid Tumor, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 completed, 1 unknown. 3 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 33Active not recruiting 1, Completed 1, Unknown 1
Phase 21Active not recruiting 1

Follow Desmoid Tumor: new trials by email Literature Review of Desmoid Tumor trials Research Report on Desmoid Tumor

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of AL102 in Patients With Progressing Desmoid Tumors
AL102, Placebo - Desmoid, Desmoid Tumor
Phase 2 / Phase 3Active not recruitingImmunome, Inc.1982021-09-012026-06-08
A Randomized, Double-blind,Phase Ⅲ Study of Liposome Doxorubicin in Desmoid Tumor
Liposome doxorubicin, Saline Solution - Desmoid Tumor
Phase 3UnknownSun Yat-sen University722020-09-292022-09-30
Nirogacestat for Adults With Desmoid Tumor/Aggressive Fibromatosis (DT/AF)
Nirogacestat oral tablet, Placebo Oral Tablet - Desmoid Tumor, Aggressive Fibromatosis
Phase 3CompletedSpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany1422019-04-172026-08-20

Narrower conditions

Desmoid Tumors (3)

Broader conditions

Fibroma (3)  ·  Neoplasms (3)  ·  Neoplasms by Histologic Type (3)  ·  Neoplasms, Connective Tissue (3)  ·  Neoplasms, Connective and Soft Tissue (3)  ·  Neoplasms, Fibrous Tissue (3)

Interventions

Saline Solution (1)  ·  nirogacestat (1)

Sponsors

Immunome, Inc. (1)  ·  SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany (1)  ·  Sun Yat-sen University (1)

Countries

Belgium (2)  ·  Germany (2)  ·  Italy (2)  ·  Netherlands (2)  ·  United Kingdom (2)  ·  United States (2)  ·  Australia (1)  ·  Canada (1)  ·  China (1)  ·  Israel (1)  ·  Poland (1)  ·  South Korea (1)  ·  Spain (1)

Top investigators

Bernd Kasper, MD (1)  ·  Mrinal Gounder, MD (1)

Results publications

PMID 36884323, PMID 37347393, PMID 41115259